-

Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors.

Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided strategic advisory services to corporate clients in the health care services industry. She began her banking career at Goldman Sachs in the Mergers & Acquisitions group and Principal Investing Area.

Ms. Cusack serves in a volunteer capacity as a trustee of Hudson Guild, a Chelsea-based settlement house providing social services to over 14,000 New Yorkers.

Ms. Cusack holds an MBA from the University of Chicago Graduate School of Business and a BA in East Asian Studies from Princeton University.

Commenting on Ms. Cusack’s appointment to the Board, Rick Matros, CEO and Chairman, said, “I first became acquainted with Katie when I engaged MTS as an advisor during the Sun Healthcare Group bankruptcy and subsequent restructuring. Since then I have enjoyed watching the journey her career has taken her on. She has been successful with every move she has made. Katie brings a unique skill set and perspective to Sabra and with the recent additions of Clif Porter and Ann Kono to the Board we have materially broadened the depth, strength and diversity of the Sabra Board. As we enter our second decade, and with the promotion of Michael Costa announced today, we believe we are positioned to move forward with a leadership team second to none.”

About Sabra

Sabra operates as a self-administered, self-managed real estate investment trust (a “REIT”) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

Contacts

Investor & Media Inquiries:
1-888-393-8248 or investorinquiries@sabrahealth.com

Sabra Health Care REIT, Inc.

NASDAQ:SBRA

Release Versions

Contacts

Investor & Media Inquiries:
1-888-393-8248 or investorinquiries@sabrahealth.com

More News From Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 third quarter earnings release on November 2, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2026 third quarter results will be held on Tuesday, November 3rd at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 833-461-5787. For participants outside the U.S., the dial-in number is 585-542-9983. The conference...

Sabra Health Care REIT, Inc., Issues Business Update and will Participate in the BofA Securities 2026 Global Real Estate Conference

TUSTIN, Calif.--(BUSINESS WIRE)--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the company’s website.In addition, Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Darrin Smith, the company’s Chief Investment Officer, and Lukas Hartwich, the company’s Executive Vice President of Finance, will participate in the BofA Securities 2026 Gl...

Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 2026. SECOND QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the second quarter of 2026 were as follows: Net Loss: $(0.10) FFO: $(0.02) Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.40 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.49x Senior Housing - Leased: 1.52x B...
Back to Newsroom